ENTITY

Dynavax Technologies (DVAX US)

4
Analysis
Health CareUnited States
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
more
Refresh
Company Presentation09 May 2024 04:30
Company Presentation01 Feb 2024 23:00
Company Presentation23 Feb 2024 05:30
Company Presentation03 Nov 2023 04:30
Company Presentation04 Aug 2023 04:30
x